Homocysteine lowering in end-stage renal disease: is there any cardiovascular benefit?
Circulation
.
2010 Mar 30;121(12):1379-81.
doi: 10.1161/CIR.0b013e3181daa7c9.
Epub 2010 Mar 15.
Authors
Lawrence de Koning
,
Frank B Hu
PMID:
20231538
DOI:
10.1161/CIR.0b013e3181daa7c9
No abstract available
Publication types
Comment
Editorial
Review
MeSH terms
Cardiovascular Diseases / etiology
Cardiovascular Diseases / prevention & control*
Homocysteine / blood
Homocysteine / drug effects*
Humans
Kidney Failure, Chronic / complications*
Kidney Failure, Chronic / therapy
Substances
Homocysteine